Multiple Myeloma clinical trials in Hawaii

2 actively recruiting multiple myeloma trials at 2 sites across Hawaii.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 2 Recruiting Academic/Other

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE:…

Sponsor: American Society of Clinical Oncology

NCT ID: NCT02693535

Sites in Hawaii:

The Queen's Medical Center - POB I — Honolulu, Hawaii
The Queen's Medical Center - Punchbowl — Honolulu, Hawaii
The Queen's Medical Center - Kuakini — Honolulu, Hawaii
The Queen's Medical Center - West Oahu — ‘Ewa Beach, Hawaii

View on ClinicalTrials.gov →

Recruiting Network

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Sponsor: Center for International Blood and Marrow Transplant Research

NCT ID: NCT01351545

Sites in Hawaii:

Kapiolani Medical Center for Women and Children — Honolulu, Hawaii

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20